Alison H. Goodall

Alison H. Goodall

Auto-generated profile, based on publicly available information

Alison H. Goodall

Department of Cardiovascular Sciences, University of Leicester and NIHR Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK

Research Focus & Metrics

Academic Career Length

53Years (1974-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2015 in Nature
Verified
Journal Article
Closed access
PDF file
ALAdam E Locke
Adam E Locke
BKBratati Kahali
Bratati Kahali
SBSonja I Berndt
Sonja I Berndt
AJAnne E Justice
Anne E Justice
TPTune H Pers
Tune H Pers
ESElizabeth K. Speliotes
Elizabeth K. Speliotes

6 March 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JCJohn F. Carlquist Cardiogenics
John F. Carlquist Cardiogenics
HSHeribert Schunkert
Heribert Schunkert
TCthe CARDIoGRAM Consortium
the CARDIoGRAM Consortium
IKInke R König
Inke R König
SKSekar Kathiresan
Sekar Kathiresan
Jeanette ErdmannJeanette Erdmann
Jeanette Erdmann

2 December 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PDPanos Deloukas
Panos Deloukas
Stavroula KanoniStavroula Kanoni
Stavroula Kanoni
CWChristina Willenborg
Christina Willenborg
MFMartin Farrall
Martin Farrall
TAThemistocles L Assimes
Themistocles L Assimes
NSNilesh J Samani
Nilesh J Samani

1 March 2012 in The Lancet
Verified
Journal Article
Open access
ICIL6R Genetics Consortium Emerging Risk Factors Collaboration
IL6R Genetics Consortium Emerging Risk Factors Collaboration
NSNadeem Sarwar
Nadeem Sarwar
ABAdam S Butterworth
Adam S Butterworth
DFDaniel F Freitag
Daniel F Freitag
JGJohn Gregson
John Gregson
JDJohn Danesh
John Danesh
Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades. To assess whether this pathway is causally relevant to coronary heart disease, we studied a functional genetic variant known to affect IL6R signalling. In a collaborative meta-analysis, we studied Asp358Ala (rs2228145) in IL6R in relation to a panel of conventional risk factors and inflammation biomarkers in 125,222 participants. We also compared the frequency of Asp358Ala in 51,441 patients with coronary heart disease and in 136,226 controls. To gain insight into possible mechanisms, we assessed Asp358Ala in relation to localised gene expression and to postlipopolysaccharide stimulation of interleukin 6. The minor allele frequency of Asp358Ala was 39%. Asp358Ala was not associated with lipid concentrations, blood pressure, adiposity, dysglycaemia, or smoking (p value for association per minor allele ≥0·04 for each). By contrast, for every copy of 358Ala inherited, mean concentration of IL6R increased by 34·3% (95% CI 30·4-38·2) and of interleukin 6 by 14·6% (10·7-18·4), and mean concentration of C-reactive protein was reduced by 7·5% (5·9-9·1) and of fibrinogen by 1·0% (0·7-1·3). For every copy of 358Ala inherited, risk of coronary heart disease was reduced by 3·4% (1·8-5·0). Asp358Ala was not related to IL6R mRNA levels or interleukin-6 production in monocytes. Large-scale human genetic and biomarker data are consistent with a causal association between IL6R-related pathways and coronary heart disease. British Heart Foundation; UK Medical Research Council; UK National Institute of Health Research, Cambridge Biomedical Research Centre; BUPA Foundation.

1 June 2014 in The Lancet
Verified
Journal Article
Closed access
KDKatherine J Dick
Katherine J Dick
CNChristopher Nelson
Christopher Nelson
LTLoukia Tsaprouni
Loukia Tsaprouni
JSJohanna K Sandling
Johanna K Sandling
DADylan Aïssi
Dylan Aïssi
NSNilesh J Samani
Nilesh J Samani

1 May 2003 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
SBScott Brouilette
Scott Brouilette
RSRavi K. Singh
Ravi K. Singh
JTJohn R. Thompson
John R. Thompson
AGAlison H. Goodall
Alison H. Goodall
NSNilesh J. Samani
Nilesh J. Samani
Objective— Biological age may be distinct from chronological age and contribute to the pathogenesis of age-related diseases. Mean telomeres lengths provide an assessment of biological age with shorter telomeres, indicating increased biological age. We investigated whether subjects with premature myocardial infarction (MI) had shorter leukocyte telomeres. Methods and Results— Mean terminal restriction fragment (TRF) length, a measure of average telomere size, was compared in leukocyte DNA of 203 cases with a premature MI (<50 years) and 180 controls. Age- and sex-adjusted mean TRF length of cases was significantly shorter than that of controls (difference 299.7±69.3 base pairs, P <0.0001) and on average equivalent to controls 11.3 years older. The difference in mean TRF length between cases and controls was not accounted for by other coronary risk factors. Compared with subjects in the highest quartile for telomere length, the risk of myocardial infarction was increased between 2.8- and 3.2-fold ( P <0.0001) in subjects with shorter than average telomeres. Conclusions— The findings support the concept that biological age may play a role in the etiology of coronary heart disease and have potentially important implications for our understanding of its genetic etiology, pathogenesis, and variable age of onset.